하루동안열지않기

Advanced Regenerative Medicine Institution

Designated by the Ministry of Health and Welfare,
Korea’s First Ophthalmology Clinic Authorized for Advanced Regenerative Medicine

Ministry of Health and Welfare Designated

Built on a nationally accredited, cutting-edge research environment,
we are setting a new standard in future medicine through integrated stem cell and genetic research.

What Is Advanced Regenerative Medicine?

Restoring fundamental function beyond
the limits of medication and surgery

For severe eye conditions that were once difficult to treat,
new possibilities are now opened through human-derived cell therapies.

Advanced regenerative medicine is an innovative approach that uses human cells to regenerate
and restore damaged tissues and functions. By combining cell therapy, gene therapy, and tissue engineering,
it aims to repair ocular tissues and improve vision. Since the eye is an “immune-privileged” organ with a lower risk of rejection,
ophthalmology is one of the leading fields in regenerative medicine research worldwide.

수술 및 약물 투여 형상 이미지

Surgery & Medication

(Limited to symptom relief and ‘maintenance’)

인체 유래 세포 형상 이미지 Stem Cell Therapy Gene Therapy

Transplantation of human-derived cells

Transplant (stem cells, immune cells)

Why Seoul BGSS Eye Clinic?

A trusted leader in regenerative medicine,
verified by rigorous national standards

To be designated as an advanced regenerative medicine provider, institutions must meet strict standards for facilities, equipment,
medical expertise, and clinical research protocols. At Seoul BGSS Eye Clinic, all key personnel have completed specialized training,
and all research and treatments are conducted under strict government oversight to ensure safety and reliability.

Government-Verified Strict Standards

  • State-of-the-Art Research Facilities

  • High-Precision Research Equipment

  • Highly Experienced Medical Professionals

  • Standard Operating Procedures (SOPs)

  • Ministry of Health and Welfare Evaluation

Vision for Advanced Regenerative Medicine Research

Opening New Pathways for Treatment in 2026

For intractable eye diseases that have shown limitations with conventional medication or surgery,
we provide next-generation medical solutions aimed at fundamental tissue regeneration

이종호 대표원장 이미지
In accordance with the
[Act on the Safety and Support of Advanced Regenerative Medicine and Advanced Biopharmaceuticals],
we are a nationally certified clinical research institution in regenerative medicine,
having passed rigorous verification processes including specialized training for key personnel,
document review, and on-site inspections

Advanced Regenerative Medicine Provider Institution

Principal Investigator: Dr. Jong-Ho Lee, Chief Director

닫기